GLP-1/GLP-2 Blend
This product is a custom blend of Tirzepatide (10mg) and Semaglutide (2mg), both peptide-based medications that regulate glucose and control appetite. It is intended for select individuals under clinical supervision.
- The description claims combining Tirzepatide and Semaglutide may produce enhanced metabolic outcomes.
- The description claims Tirzepatide provides stronger reductions in HbA1c and body weight compared to Semaglutide alone.
Variants (1)
- Default Title — 165.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
72%